Heron Therapeutics Leads High Short Interest Stocks with 3.46% Gain
0h ago|5 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
short-interestheron-therapeutics
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.
Heron Therapeutics stock rose 3.46% to $0.32 on August 21, 2026, leading a group of stocks with significant short interest. Beyond Meat gained 1.1% to $14.64, while Beam Global declined 5.88% to $1.28. Benzinga published the performance data, highlighting the divergent moves among heavily shorted equities as a focal point for both bullish and bearish traders seeking to profit from volatility.
High short interest levels often reflect concentrated bearish sentiment, but they also create conditions for rapid price reversals. Stocks with elevated short interest are prone to short squeezes, where covering activity can trigger a sharp rally. Market participants now scrutinize these levels more closely for both directional and contrarian signals.
The current environment features several stocks in prolonged downtrends. Heron Therapeutics has traded between $0.2975 and $1.575 over the past 52 weeks, indicating extreme volatility. Beyond Meat's 52-week range spans from $10.71 to $230.7, illustrating a massive drawdown from previous highs.
A key catalyst for monitoring these stocks is the publication of official short interest data, which exchanges release on a monthly basis. This data provides a delayed but formal snapshot of bearish positioning. Real-time sentiment, however, can diverge significantly from these reports.
The last major wave of retail-driven short squeezes, exemplified by the GameStop event of early 2021, demonstrated the explosive potential when high short interest meets coordinated buying pressure. That precedent remains a reference point for traders evaluating current setups.
The data reveals starkly different financial profiles among the highlighted stocks. Heron Therapeutics has a market capitalization of $60.70 million with 189.85 million shares outstanding. Its average trading volume is 3.48 million shares, against a daily volume of 0.41 thousand shares on the report date, suggesting unusually low activity.
Beyond Meat's market cap stands at $251.72 million with 17.19 million shares outstanding. Its average daily volume is 1.35 million shares. Beam Global has a market cap of $28.42 million with 22.20 million shares outstanding and an average volume of 1.88 million shares.
Performance on August 21 was mixed. The table below shows the key moves:
| Symbol | Company | % Change | Price |
|---|---|---|---|
| HRTX | Heron Therapeutics | +3.46% | $0.32 |
| BYND | Beyond Meat | +1.1% | $14.64 |
| BEEM | Beam Global | -5.88% | $1.28 |
None of these stocks pay a dividend, with yields listed as N/A or 0%.
The days-to-cover ratio, calculated as short shares divided by average daily volume, is a critical metric derived from short interest. A high ratio indicates greater bearish conviction and a longer potential covering period. The source material does not provide the specific days-to-cover figures for these stocks.
Comparing these micro-cap and small-cap stocks to the broader market is challenging without a specified benchmark index level from the source. Their volatility typically far exceeds that of major indices like the S&P 500.
The moves suggest sector-specific pressures are interacting with short positioning. Heron Therapeutics' gain may reflect specific developments in its biopharmaceutical pipeline, which focuses on postoperative pain and chemotherapy-induced nausea. Beam Global's decline of nearly 6% indicates continued skepticism toward its solar-powered EV charging business model, despite the growing emphasis on clean energy.
Second-order effects could include increased volatility in related sectors. A sustained short squeeze in one heavily shorted biotech stock might temporarily lift sentiment across the speculative healthcare sector. Conversely, persistent selling in a clean-tech name like Beam could weigh on other small-cap renewable energy plays.
A key limitation of this analysis is the source's inclusion of two tickers, BLNKW and ARCH, with prices listed as $0.000000 and no accompanying descriptive text. This presents incomplete data, making any substantive analysis of those specific equities impossible. The article's focus appears to be on HRTX, BYND, and BEEM.
Positioning flows are bifurcated. Bearish traders are likely maintaining or initiating shorts in names like Beam Global, betting on the continuation of the downtrend. Contrarian or momentum traders may be probing for long entries in gainers like Heron Therapeutics, anticipating a squeeze or trend reversal.
Traders should monitor the next official short interest data publication from Nasdaq and the NYSE, typically released bi-monthly around the middle and end of each month. These reports will confirm whether bearish bets have increased or begun to unwind.
Key price levels to watch include Heron Therapeutics' 52-week high of $1.575, which represents a significant resistance point. Beyond Meat's 52-week low of $10.71 is a critical support level; a break below could trigger another wave of selling. For Beam Global, the $1.00 psychological level is near its 52-week low of $0.9653.
Upcoming earnings reports for these companies will serve as major catalysts. While the source does not provide specific earnings dates, quarterly filings typically occur in the weeks following the end of a financial quarter. Any guidance updates on revenue, cash burn, or path to profitability will directly impact short-seller theses.
Market-wide risk sentiment, often dictated by Federal Reserve policy and macroeconomic data, will influence capital flows into these high-risk, high-short-interest names. A shift toward a 'risk-on' environment could accelerate covering activity.
A high short interest percentage, often expressed as the number of shorted shares divided by total float, indicates a large proportion of traders are betting the stock's price will fall. It is a direct gauge of bearish market sentiment. For example, a rise from 20% to 30% short interest means significantly more investors believe the stock will weaken. However, extreme short interest can also be a contrarian indicator, as it sets the stage for a short squeeze if positive news forces bears to cover their positions rapidly.
The days-to-cover ratio is calculated by dividing the total number of shares sold short by the stock's average daily trading volume. This yields the average number of days it would take for all short-sellers to close their positions. A high ratio, such as 10 days or more, suggests intense bearish sentiment and implies a covering rally could be prolonged if triggered. A low ratio indicates short-sellers could exit quickly, potentially limiting the magnitude of a squeeze. This metric helps traders assess the potential duration and intensity of a short-covering event.
The primary risk is a short squeeze, where unexpected positive news or coordinated buying forces short-sellers to repurchase shares to limit losses, driving the price higher rapidly. Stocks in downtrends can reverse quickly. Another risk is using outdated information, as official short interest reports are published monthly and may not reflect real-time positioning. Finally, focusing solely on short opportunities can cause traders to miss profitable long positions in other assets, reducing portfolio diversification. Unlimited loss potential exists if a shorted stock rises significantly.
Heavily shorted stocks like Heron Therapeutics and Beyond Meat offer high-risk opportunities defined by the tension between bearish bets and the latent threat of a violent squeeze.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
AiX is our free MetaTrader 4 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.